Shaanxi Journal of Medical Laboratory Sciences 2006 Issue 5 bao chi te se , zai chuang hui huang wei guo wai yi xue yao xue fen ce gai kan ming er zhi du zhe

bao chi te se , zai chuang hui huang wei guo wai yi xue yao xue fen ce gai kan ming er zhi du zhe
guo ji yao xue yan jiu za zhi bian ji bu

..............page:1-3

ai zi bing da shu mo xing
zhang zuo

..............page:3

xue qing xian zuo tuo an mei zai shang han zao qi zhen duan zhong de jia zhi
wang zuo ; cheng mao liang

..............page:64-65

yi yao xin xi

..............page:62-63

Glycogen synthase kinase-3 and its inhibitors:a research development
zuo ming xin ; chen xiao guang

..............page:60-61

cetp yi zhi ji zeng jia gao mi du zhi dan bai dan gu chun de shui ping
xing shuang

..............page:54-55

Quantitative structure-activity relationships beyond 3D
li ren li

..............page:55-56

kang jing shen bing yao shi ti zhong zeng jia zhi mi de xian suo
luo xiao ru

..............page:53

wu shu yi xing xue yin qi xue xing jian ding kun nan yi li bao gao
chen chen ; zhang xian qing ; mu shi jie ; xia ai jun ; zhang yu hong

..............page:72-73

fei yan zhi yuan ti kuai su jian ding pei yang ji zai er tong zhi yuan ti gan ran kuai su zhen duan zhong de ying yong
qian xin hong ; zhang guo cheng ; xu dong liang

..............page:71-72

mai rui bc-3000plus xue xi bao ji shu yi chang jian gu zhang de fen xi
xie qing ping ; xu xiu qin

..............page:70

The Relationship between Serum Level of PCⅢ and the Liver Fibrosis Activity
wang hui ; hui xiao yang ; li wen jie ; xu yu ; fan hua jie ; du da hai

..............page:68-70

yi xue shi yan shi de xian dai hua guan li liu xi ge ma
pan li lan

..............page:81-83

lin chuang xue ye xi bao xue fen xi de quan cheng zhi liang kong zhi
yin bin xia ; wang xiang ling ; gao ning

..............page:78-80

jiao ru ning ji fa ce ding tang hua xue hong dan bai (hbalc) de tan tao
zhang jun ; gu yi hai

..............page:94

lao nian nan xing you yang yun dong yu no xiang guan xing yan jiu
mao hong ni ; zhang yu ; sha peng

..............page:93

zi zhi hbsag zhi kong wu ji ying yong
huang guang wu ; wang bin

..............page:88

ren lei wei xiao bing du b19 de jian ce fang fa ji jin zhan
li zuo na ; yang li ya

..............page:89-90

xue xiao ban ji shu pian di wu cha shi yan tan tao ji dui ce
cheng zuo ; liu geng fu ; yuan gui rong ; wang wen lan ; zuo fang

..............page:91-92

kang gao xue ya yao wu fan ying yu ce
tang zhi hui

..............page:10

Clinial application of endothelin receptor antagonists in treatment of pulmonary hypertension
jiang lei fu ; wang hong

..............page:11-13

A new potential target of asthma therapy:T cell immunoglobulin-and mucin-domain-containing molecule-3
weng xiao jing ; zhang hong quan

..............page:13

hgf ji c-met ba xiang yao wu zhi liao zhong liu de xi wang tiao zhan ji wei lai
qiao hong

..............page:18

jie kai xin shuai de fen zi ji zhi
gao ling

..............page:6

-3 duo bu bao he zhi fang suan he xin fang chan dong
huang ling zhi

..............page:7-10

kang ni zhuan lu bing du zhi liao hiv gan ran bing ren de xin xue guan bing wei xian xing
huang shi jie

..............page:4-6

cong saprosmaf ragrans zhong fen li de xin xing kang jun zuo zuo
xu liang

..............page:47

hiv-1 qin ru yi zhi ji de yan jiu jin zhan
xiao zhong hai ; zhang shou guo

..............page:45-47

tetramic he tetronic suan zuo wei - fen mi mei yi zhi ji
xu liang

..............page:48-49

A multiple-unit floating drug delivery system:research progress
zhang an yang ; fan tian yuan

..............page:39-41

jun shi yi xue ke xue yuan du wu yao wu yan jiu suo jian jie

..............page:36-38

Application of supercritical CO_2 flnid technique to particle encapsulation with polymers
ma xiao wen ; mo zuo ; song hou yan

..............page:38

zhi liao pa jin sen bing de xin ba dian
liu jing ; wang lin

..............page:16-18

ti mi sha tan yu an lv di ping he yong dui gao xue ya he bing tang niao bing huan zhe niao bai dan bai pai xie lv de ying xiang
xin hai li

..............page:14-15

zhong liu de mian yi zhi liao : gai bian ping heng
song zuo

..............page:25-27

ru xian ai de shuang ba biao zhi liao
lu zuo

..............page:24

zhong liu ji yin tu bian de zhong da fa xian
jiang fan

..............page:27-28

diao jie fc shou ti : zhi liao yan zheng zi shen mian yi bing ji zhong liu de xin tu jing
cui dong xue

..............page:19-21

zhong liu de xiu fu liao fa
li jin bin

..............page:22-24

duo zuo he dan bai lei yao wu kou fu gei yao de ke xing xing tan tao
huang jian ; gao chun sheng ; mei xing guo

..............page:43-44

To Ensure Quality of Hematology Testing by Participating CAP Proficiency Testing
wang yue ; sun zuo ; wang hou fang ; liu jie

..............page:74-75

Participate College of American Pathologist (CAP) Proficiency Testing to Improve Laboratory Performance on Testing Tumor Markers and Hormones
fang hui ; mu zuo ; sun zuo

..............page:76-78

dh-505a dian jie zhi fen xi yi de chang jian gu zhang fen xi yu chu li
guo xiao dong ; zhou yi

..............page:73

Advancement on combined application of percutaneous permeation methods
wang zuo ; gao shen

..............page:42-43

Self-emulsifying drug delivery systems:a recent development
feng yao rong ; cheng qiao yuan ; li fan zhu

..............page:41

da suan su dui nai jia yang xi lin jin huang se pu tao qiu jun de ti wai kang jun huo xing tan tao
wen ping ; chen lei ; guo yue fang

..............page:86-87

ji ceng shi yan shi de zhi liang kong zhi xian zhuang ji gai jin fang an
yang jie

..............page:85-86

le shan shi xue zhan xue ye shai jian zi dong hua de shi shi
deng xiao qin ; yang mao ; mao jian jun ; zhang ling ; yang yong hong ; shuai min ; xiang yan ling

..............page:83-84

xuan ze xing zuo yong yu yi xian ai yi ai ji yin dpc4 que xian de fen zi
liu yuan jiang

..............page:21

Detection of Soluble Endothelial Cell Protein C Receptor (sECPCR) in Patients with Systemic Lupus Erythematosus (SLE) and to Evaluate the Clinical Significance
dong cun yan ; zhou zhi fang ; you li

..............page:66-67

ri li 7080 sheng hua fen xi yi yi li yi wai gu zhang ji chu li
zhang chang li ; mei yong chun ; xue liang

..............page:65

Progress of pharmacological research on alpha-linolenic acid
wang hong zuo ; zuo shan ; sun ji yuan

..............page:59

Progress in the study of combining morphine and low-dose opioid receptor antagonists
gao ming long ; liu yong zhe ; zhang hong

..............page:58-59

Advancement of investigation on cytotoxicity and mechanism of pyrrolizidine alkaloids
wang jun ; wang chang hong ; wang zuo tao

..............page:57

yan zheng fan ying he zhong liu
huang ling zhi

..............page:31-32

gdan bai ou lian shou ti : ji huo b lei gpcr de xin kai guan
gao ling

..............page:51

xian li ti ci ji su shou ti de xin gong neng
huang ling zhi

..............page:52-53

dna de ying ji xing sun shang
yao zhen yu

..............page:49

diao jie tian ran mian yi li de duo zuo idr-1
liu yuan jiang

..............page:50-51

microrna yi zhi zhong liu
xing shuang

..............page:29-31

shi ai xi bao si wang bei zeng de xin tu jing
luo xiao ru

..............page:33-34

pten ji yin zu de xin bao hu yin zi
huang ling zhi

..............page:34-35